Claudio Mori

Claudio Mori

Company: Vifor Pharma

Job title: Medical Strategy & Portfolio Lead

Bio:

Claudio Mori is the Medical Strategy/Portfolio Lead and Global Medical Lead Ferroportn‐Inhibitor,  Director, at Vifor Pharma Ltd, Zurich, Switzerland. He graduated from the University of Zurich  Medical School, Switzerland. After basic research in Microbiology and clinical experience in General  and Internal Medicine, always focusing on Cardiology, he joined the pharmaceutical industry as  Medical Advisor Cardiovascular at Bristol Myers Squibb GmbH, Baar, Switzerland. In this position, he  was responsible for the products pravastatin, irbesartan and about 15 cardiovascular compounds (no  promotion).  Before  moving  to  Vifor  Pharma,  he  worked  as  Regional  Medical  Liaison  CV&Rheumatology  in  Spain/Portugal  for  Centocor  B.V.,  Leiden,  Netherlands,  responsible  for  abciximab and infliximab, respectively. In Vifor Pharma, he started in the Clinical Development being  responsible for starting and developing Cardiology by designing FAIR‐HF, CONFIRM‐HF, EFFECT‐HF  and  implementing  and  comprehensive  IIT  study  program,  developing  further  Nephrology  by  designing the FIND‐CKD and Gastroenterology the FERGICore, FERGIMain studies. He started to build  up  the  Medical  Affairs  functions  and  subsequently  been  appointed  as  Medical  Affairs Director  Cardiology and Nephrology to launch ferric carboxymaltose (Ferinject®).  Lastly, Claudio Mori was  responsible as the Scientific Advisor Cardiovascular for the strategy and life cycle management in  regards of data generation and clinical study plan for patiromer, a novel potassium‐binder. The  current role as Medical Strategy and Portfolio Lead includes the oversight, development, inputs into  the product and portfolio strategy, support to clinical development activities as well as team and  matrix management.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.